Bumper Offer - Urjas oil Just @ Rs. 1
Apeton (Olcare) is a prescription drug, available for use as Syrup. Anorexia Nervosa, Loss of appetite are some of its major therapeutic uses. Secondary and off-label uses of Apeton (Olcare) have also been mentioned below.
The right dosage of Apeton (Olcare) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Apeton (Olcare) have been listed ahead. These side effects of Apeton (Olcare) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Apeton (Olcare)'s effect during pregnancy is Safe and Moderate while nursing. In addition, Apeton (Olcare)'s effects on the liver, heart and kidney are discussed below in the Apeton (Olcare) related warnings section.
Apeton (Olcare) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Peptic Ulcer are examples of such conditions. Some other conditions that can be affected by Apeton (Olcare) are listed in the contraindications section below.
Drug interactions for Apeton (Olcare) have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Apeton (Olcare), it is important to know that it is not safe while driving, and is not habit-forming.
Apeton (Olcare) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Apeton (Olcare) is used -
Moderate
Mild
Is the use of Apeton (Olcare) safe for pregnant women?
Apeton is safe for pregnant women.
Is the use of Apeton (Olcare) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Apeton. Immediately discontinue Apeton if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Apeton (Olcare) on the Kidneys?
There are no side effects of Apeton on the kidneys.
What is the effect of Apeton (Olcare) on the Liver?
Side effects of Apeton rarely affect the liver.
What is the effect of Apeton (Olcare) on the Heart?
Very few cases of side effects of Apeton on the heart have been reported.
Apeton (Olcare) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Apeton (Olcare) unless your doctor advises you to do so -
Is this Apeton (Olcare) habit forming or addictive?
No, you will not get addicted to Apeton (Olcare).
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Apeton (Olcare) can make you feel drowsy.
Is it safe?
Yes, but take Apeton (Olcare) only as per medical advice.
Is it able to treat mental disorders?
No, Apeton (Olcare) cannot treat any kind of mental disorder.
Interaction between Food and Apeton (Olcare)
Taking Apeton (Olcare) with food does not cause any problems.
Interaction between Alcohol and Apeton (Olcare)
Taking alcohol with Apeton (Olcare) can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyproheptadine HCI
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 174
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyproheptadine HCI
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 174
